Senseonics Holdings, Inc. Common Stock - Asset Resilience Ratio

Latest as of September 2025: 54.67%

Senseonics Holdings, Inc. Common Stock (SENS) has an Asset Resilience Ratio of 54.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SENS liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

$76.49 Million
Cash + Short-term Investments

Total Assets

$139.92 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Senseonics Holdings, Inc. Common Stock's Asset Resilience Ratio has changed over time. See SENS net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Senseonics Holdings, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Senseonics Holdings, Inc. Common Stock.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $76.49 Million 54.67%
Total Liquid Assets $76.49 Million 54.67%

Asset Resilience Insights

  • Very High Liquidity: Senseonics Holdings, Inc. Common Stock maintains exceptional liquid asset reserves at 54.67% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Senseonics Holdings, Inc. Common Stock Industry Peers by Asset Resilience Ratio

Compare Senseonics Holdings, Inc. Common Stock's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
GN Store Nord
CO:GN
Medical Devices -4.56%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Shanghai Kinetic Medical Co
SHE:300326
Medical Devices 28.89%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%

Annual Asset Resilience Ratio for Senseonics Holdings, Inc. Common Stock (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Senseonics Holdings, Inc. Common Stock.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% $0.00 $100.44 Million --
2023-12-31 24.42% $33.75 Million $138.22 Million -36.50pp
2022-12-31 60.91% $108.22 Million $177.67 Million +12.43pp
2021-12-31 48.48% $96.44 Million $198.93 Million --
2020-12-31 0.00% $0.00 $35.92 Million --
2018-12-31 0.00% $0.00 $159.97 Million --
2017-12-31 44.18% $20.30 Million $45.94 Million +11.45pp
2016-12-31 32.74% $7.29 Million $22.27 Million -3.73pp
2014-12-31 36.46% $7.29 Million $20.00 Million --
pp = percentage points

About Senseonics Holdings, Inc. Common Stock

NYSE MKT:SENS USA Medical Devices
Market Cap
$259.04 Million
Market Cap Rank
#15657 Global
#3593 in USA
Share Price
$6.34
Change (1 day)
+2.92%
52-Week Range
$0.41 - $8.47
All Time High
$8.47
About

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more